What is the appropriate management of a bleeding anal fistula?

Management of Bleeding Anal Fistula

For a bleeding anal fistula, immediate assessment for abscess is mandatory with surgical drainage if present, followed by seton placement combined with antibiotics (metronidazole and/or ciprofloxacin) as the preferred initial strategy, with anti-TNF therapy (infliximab or adalimumab) reserved for complex or refractory cases. 1

Initial Assessment and Imaging

Rule out abscess first - More than two-thirds of patients with anal fistulas have an associated abscess that must be drained before any definitive intervention. 1 The bleeding you observe may indicate active inflammation or associated sepsis requiring urgent drainage.

• Obtain contrast-enhanced pelvic MRI as the initial imaging procedure to assess the fistula anatomy and identify any occult abscess collections. 1
• Perform proctosigmoidoscopy routinely to evaluate for concomitant rectosigmoid inflammation, as this has prognostic and therapeutic relevance. 1
• Examination under anesthesia (EUA) is considered the gold standard when performed by an experienced surgeon, particularly if imaging suggests complex anatomy. 1

Classification Determines Treatment Approach

Classify the fistula as simple (subcutaneous, low intersphincteric, or low transsphincteric) versus complex (high transsphincteric, suprasphincteric, extrasphincteric, or associated with multiple tracts). 1 This distinction is critical as it fundamentally changes management.

Treatment Algorithm

If Abscess is Present:

• Drain immediately via examination under anesthesia. 1
• Place a loose (non-cutting) seton after drainage to maintain drainage and prevent recurrent abscess formation. 1
• Do NOT attempt fistulotomy in the acute setting when abscess is present. 1

For Simple Fistulas (After Abscess Excluded/Drained):

First-line: Seton placement combined with antibiotics (metronidazole and/or ciprofloxacin). 1

• Simple fistulotomy may be considered ONLY for uncomplicated low anal fistulas by experienced surgeons, but carries risk of sphincter injury. 1
• Second-line (if refractory to antibiotics): Thiopurines or anti-TNF agents (infliximab or adalimumab). 1

For Complex Fistulas:

Mandatory approach: 1

1. Drain any sepsis via EUA
2. Place loose seton after surgical drainage
3. Initiate medical therapy

Medical therapy options for complex fistulas: 1

• Infliximab (first-line biologic) - Level 1 evidence for fistula closure and maintenance. 1
• Adalimumab - Level 2 evidence as alternative anti-TNF. 1
• Combination therapy: Seton drainage plus anti-TNF shows superior results compared to either alone. 1

Maintenance therapy: Use thiopurines, infliximab, adalimumab, seton drainage, or combination of drainage and medical therapy. 1

Surgical Options for Definitive Closure

These should only be attempted after sepsis is controlled, in symptomatic patients with no concomitant abscess and medically controlled proctitis. 1

Available techniques include: 1

• Chronic seton (may be definitive treatment with medical therapy)
• Mucosal advancement flap (64% success in Crohn's-related fistulas) 1
• Ligation of intersphincteric fistula tract (LIFT)
• Fibrin glue (38-50% closure rates, but variable) 1, 2
• Fistula plug (55% success rate) 1
• Video-assisted anal fistula treatment (VAAFT)

Important caveat: Surgical options beyond seton placement should only be offered in selected patients after counseling, as long-term results are poor, particularly for complex disease with ongoing activity. 1

Critical Pitfalls to Avoid

• Never perform fistulotomy for high or complex fistulas - this risks incontinence from sphincter division. 1
• Do not use cutting setons in any fistula - they may result in keyhole deformity and fecal incontinence. 1
• Do not surgically treat concomitant perianal skin tags - this can lead to chronic non-healing ulcers. 1
• Do not probe for fistulas when no obvious tract is identified during abscess drainage - this causes iatrogenic complications. 1

Refractory Disease

For patients failing medical and surgical management: 1

• Consider fecal diversion with ostomy (but counsel that reversal rates are low)
• Proctectomy as last resort for intractable disease

Monitoring Response

Clinical assessment (decreased drainage) is usually sufficient for routine follow-up. 1 MRI or anal endosonography combined with clinical assessment is recommended to evaluate fistula tract inflammation improvement when considering treatment modifications. 1